As of yet, season 3 hasn't been confirmed, but that hasn't stopped the show's producers from calling on the fans for their unwavering support.
Naturally, the conversation did turn to the future of the series, with one user commenting on the visuals of the past two seasons and whether season 3 will be "able to level up again and be even better".
"If we’re going to make a season 3, it’s going to take all the support and energy from the fans. I learned that from Akira Toriyama himself! May the great Akira Toriyama Rest in Peace."
Read more:
Dexter: Resurrection confirms release date on Paramount+Thunderbolts* Rotten Tomatoes score revealedThe show has proven to be a major hit for streaming platform Crunchyroll, with fans praising the stunning animation and the gripping story at the heart of season 2. So, we're sure this won't be the last we see of the series.
"It’s a rare kind of series. This has been a truly special experience in our careers."
Solo Leveling is available to watch on Crunchyroll.
Check out more of our Fantasy coverage or visit our TV Guide and Streaming Guide to find out what’s on. For more from the biggest stars in TV, listen to The Radio Times Podcast.
Hence then, the article about solo leveling producers call for fans help with season 3 renewal was published today ( ) and is available on Radio Times ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Solo Leveling producers call for fans' help with season 3 renewal )
Also on site :
- 2026 ASCO .. Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
- D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
- Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026